Obesity drugs, insurance companies are related to treatment persistence

Obesity drugs, insurance companies are related to treatment persistence

DALLAS – Anti-obesity drug use may depend on certain factors, according to a retrospective cohort study. In a sample of patients who filled at least one prescription for an anti-obesity drug, 44% were still taking the medication after 3 months, a percentage that dropped to 33% after 6 months and just 19% after 1 year, … Read more

Europe’s resilience depends on its ability to innovate

Europe's resilience depends on its ability to innovate

In the face of continuing global geopolitical instability, Europe is increasingly paying attention to its sovereignty, security and resilience. The availability of vital medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, policies that can build health resilience and strengthen health systems are coming into … Read more

Ozempic, Wegovy costs could put companies out of business: Blackstone CEO

Ozempic, Wegovy costs could put companies out of business: Blackstone CEO

Wegovy injection pen Michael Siluk/UCG/Universal Images Group via Getty Images Executives at a health care conference debated whether employers should pay for workers’ diet pills. A Blackstone executive warns that the expensive GLP-1 drug could put some employers out of business. Panelists agreed that companies providing drugs should do so as part of a broader … Read more

Gambling companies forced to pay around 100 million a year to the NHS | Gambling

Gambling The levy will be used to fund addiction research, prevention and treatment as part of the government’s reform plan Gambling companies will be forced to pay around $100m a year to the NHS to fund research, prevention and treatment of addiction, as part of government changes to replace the contributions system long-standing volunteering. Under … Read more

How CMS’s 2024 Risk Adjustment Rule Could Affect Palliative Care Companies

How CMS's 2024 Risk Adjustment Rule Could Affect Palliative Care Companies

Depending on how stakeholders play their cards, the U.S. Centers for Medicare & Medicaid Services (CMS) updated risk adjustment policy could lead to belt tightening or a golden opportunity for providers. provides palliative care in Medicare Advantage. The majority of palliative care provided to US patients is currently reimbursed through risk-based models such as Medicare … Read more